2 Pharma Stocks React to Quarterly Results, Guidance

Pfizer Inc (NYSE:PFE) shares are down 3.2% to trade at $25.40 at last check, despite surpassing earnings and revenue expectations for the fourth quarter. The drugmaker has struggled with weak demand for its Covid-19 vaccine, and reaffirmed its lackluster outlook for 2026.Overhead pressure near the $27 level has been capping gains since November, though the equity still sports a 13.1% nine-month lead. PFE is on track to snap a three-day win streak with its worst loss since December, and earlier gapped below ...